Survival with in-operable non-small cell lung cancer in U.K district general hospital: Is chemotherapy better than active supportive care?

A. Ali, R. Lewis (Worcester, United Kingdom)

Source: Annual Congress 2010 - Best supportive care and palliation for lung cancer patients
Session: Best supportive care and palliation for lung cancer patients
Session type: Thematic Poster Session
Number: 3295

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Ali, R. Lewis (Worcester, United Kingdom). Survival with in-operable non-small cell lung cancer in U.K district general hospital: Is chemotherapy better than active supportive care?. Eur Respir J 2010; 36: Suppl. 54, 3295

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Palliative care or standard chemotherapy in lung cancer patients?
Source: Annual Congress 2012 - Ethics Grand Round: an interactive session
Year: 2012


The role of palliative radiotherapy in locally advanced non small cell lung cancer
Source: Annual Congress 2007 - Therapy of lung cancer
Year: 2007



Integration of palliative care from the very beginning to the very end in a patient with metastasised non-small cell lung cancer
Source: International Congress 2018 – CC3 Lung cancer: personalised treatment and palliative care
Year: 2018


Expressed wishes and incidence of euthanasia in advanced lung cancer patients},
Source: Eur Respir J 2012; 40: 949-956
Year: 2012



Curative treatment vs. best supportive care in advanced non small cell lung cancer in aged person
Source: Annual Congress 2011 - Quality management for lung cancer patients
Year: 2011

Lung cancer treatment strategies in a district general hospital
Source: Eur Respir J 2006; 28: Suppl. 50, 750s
Year: 2006

Lung cancer treatment strategies in district general hospital
Source: Annual Congress 2007 - Therapeutic approaches in thoracic oncology
Year: 2007


Osimertinib as a second-line treatment for EGFR-mutated non-small cell lung cancer: the experience of a Pulmonology department
Source: Virtual Congress 2020 – Real-world data and registries of thoracic oncology
Year: 2020


Palliative care specific for lung cancer
Source: International Congress 2018 – Palliative care specific for respiratory diseases
Year: 2018


Some characteristics of patients with lung cancer elected for palliative treatment
Source: Eur Respir J 2003; 22: Suppl. 45, 432s
Year: 2003

Patient-reported outcome measures: do they improve the quality of supportive care in advanced non-small cell lung cancer?
Source: Virtual Congress 2021 – Therapy of lung cancer
Year: 2021


Comparison of non-small cell lung cancer (NSCLC) management and survival in 1995 and 2005 at a London teaching hospital
Source: Annual Congress 2008 - Management, quality aspects and prognosis in thoracic oncology
Year: 2008


The lung cancer patient, the pneumologist and palliative care: a developing alliance
Source: Eur Respir J 2015; 45: 211-226
Year: 2015



Patient experiences of home-based rehabilitation during treatment for inoperable lung cancer.
Source: International Congress 2018 – Telehealth, home rehabilitation and specific adaptations to exercise interventions in different settings
Year: 2018




Weekly administration of gemcitabine in outpatient clinic for the patients with recurrent non-small cell lung cancer after pulmonary resection
Source: Eur Respir J 2006; 28: Suppl. 50, 781s
Year: 2006

Surgery for elderly early-stage non-small cell lung cancer: less or more?
Source: International Congress 2019 – All aspects of general thoracic surgery
Year: 2019



An educational intervention for lung cancer patients treated with chemotherapy: a first evaluation
Source: Annual Congress 2007 - Nurses' involvement in the follow-up of patients with COPD and lung cancer
Year: 2007



Panel discussion: ICU admission of lung cancer patients – Is COVID-19 a game-changer?
Source: ERS webinar 2022

Access for REGISTERED non-members

Year: 2022

Patient and doctor delays in the diagnosis and treatment of non-small cell lung cancer in Turkey
Source: Annual Congress 2013 –Quality management in thoracic oncology
Year: 2013

Salvage surgery in patients with locally advanced non-small cell lung cancer – outcomes and longtime results
Source: Virtual Congress 2021 – Therapy of lung cancer
Year: 2021